The U.S. Food and Drug Administration expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new treatments to patients who need them. Image for illustration purposes

South Texas Health System Children’s and Spirit Halloween marked another year of their partnership supporting hospitalized children in the Rio Grande Valley, with organizers saying more than $380,000 has been raised for the hospital since 2018.

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.